Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OxyLight 2.0

K-Number: K202175 · 2021-12-02

Decision Date2021-12-02
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

OxyLight 2.0 is a medical device manufactured by Raja Trading Company, Inc.. It received FDA 510(k) clearance on 2021-12-02 under approval number K202175. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OxyLight 2.0?

OxyLight 2.0 is a medical device that received FDA 510(k) clearance on 2021-12-02. It is manufactured by Raja Trading Company, Inc.. The 510(k) number is K202175.

When was OxyLight 2.0 approved by the FDA?

OxyLight 2.0 received FDA 510(k) clearance on 2021-12-02, under approval number K202175.

What company makes OxyLight 2.0?

OxyLight 2.0 is manufactured by Raja Trading Company, Inc..

What is the FDA product code for OxyLight 2.0?

The FDA product code for OxyLight 2.0 is GEX. This falls under the Gastroenterology category.

Other Devices by Raja Trading Company, Inc.

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.